Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 04/02/15

TPB Publications

2007 Publications

  1. Parise, R. A., M.J. Egorin, J.L. Eiseman, E. Joseph, J.M. Covey, & J.H. Beumer, J. H., 2007. Quantitative Determination of the Cytidine Deaminase Inhibitor Tetrahydrouridine (THU) in Mouse Plasma by Liquid Chromatography/electrospray Ionization Tandem Mass Spectrometry. Rapid Comm. Mass Spectrom., 21, 1991-1997.
  2. Page J.G., B. Tian, K. Schweikart, J. Tomaszewski, R.D. Harris, T.L. Broadt, J.A. Polley-Nelson, P.E. Noker, M. Wang, S. Makhija, R. Aurigemma, D.T. Curiel, and R.D. Alvarez , 2007. Identifying the Safety Profile of a Novel Infectivity Enhanced Conditionally Replicative Adenovirus (CRAd), Ad5-24-RGD, in Anticipation of a Phase I Trial for Recurrent Ovarian Cancer. Am J Obstet Gynecol 196:389; discussion e1-389.e10.
  3. R.M. Myers, S.M. Greiner, M.E. Harvey, G. Griesmann, M.J. Duffel, S.A. Buhrow, J.M. Reid, M. Federspiel, M.M. Ames, D. Dingli, K. Schweikart, A. Welch, A. Dispenzieri, K-W Peng, and S.J. Russell, 2007. Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide. Clin Pharmacol Ther 82: 700-710.

About the Branch Chief

For information regarding the TPB, please contact Dr. Jerry M. Collins, Associate Director,